Advanced Biomed Common Stock Fundamentals
| ADVB Stock | 0.29 0.05 14.71% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Advanced Biomed's long-term financial health and intrinsic value.
At present, Advanced Biomed's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Interest Income is expected to grow to about 64.6 K, whereas Depreciation And Amortization is forecasted to decline to about 11.7 K. Advanced | Select Account or Indicator | Build AI portfolio with Advanced Stock |
Advanced Biomed Common Company Shares Owned By Insiders Analysis
Advanced Biomed's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Advanced Biomed Shares Owned By Insiders | 77.53 % |
Most of Advanced Biomed's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Biomed Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Advanced Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Advanced Biomed is extremely important. It helps to project a fair market value of Advanced Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Advanced Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Advanced Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Advanced Biomed's interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 77% of Advanced Biomed Common are shares owned by insiders. This is much higher than that of the Health Care Equipment & Supplies sector and notably higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Advanced Biomed Common Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Advanced Biomed's current stock value. Our valuation model uses many indicators to compare Advanced Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Advanced Biomed competition to find correlations between indicators driving Advanced Biomed's intrinsic value. More Info.Advanced Biomed Common is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Advanced Biomed's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Advanced Biomed's earnings, one of the primary drivers of an investment's value.Advanced Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Biomed's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Biomed could also be used in its relative valuation, which is a method of valuing Advanced Biomed by comparing valuation metrics of similar companies.Advanced Biomed is currently under evaluation in shares owned by insiders category among its peers.
Advanced Fundamentals
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 3.69 M | ||||
| Shares Outstanding | 21.64 M | ||||
| Shares Owned By Insiders | 77.53 % | ||||
| Shares Owned By Institutions | 1.21 % | ||||
| Number Of Shares Shorted | 662.89 K | ||||
| Price To Book | 2.10 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (181.46 K) | ||||
| Short Ratio | 0.43 X | ||||
| Earnings Per Share | (0.17) X | ||||
| Number Of Employees | 31 | ||||
| Market Capitalization | 6.31 M | ||||
| Total Asset | 6.51 B | ||||
| Retained Earnings | (19.23 B) | ||||
| Working Capital | 318.65 K | ||||
| Net Asset | 6.51 B |
About Advanced Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Biomed Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Biomed Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 12.3 K | 9.2 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Advanced Biomed Piotroski F Score and Advanced Biomed Altman Z Score analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.